Filing Details

Accession Number:
0000914190-15-000316
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-12 16:40:59
Reporting Period:
2015-08-10
Filing Date:
2015-08-12
Accepted Time:
2015-08-12 16:40:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180145 Cardiovascular Systems Inc CSII Surgical & Medical Instruments & Apparatus (3841) 411698056
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1358186 G Brent Blackey 1225 Old Highway 8 Nw
St. Paul MN 55112
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-12 2,500 $22.74 59,645 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2015-08-10 2,541 $0.00 2,541 $0.00
Common Stock Restricted Stock Units Acquisiton 2015-08-10 5,294 $0.00 5,294 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,541 2019-08-15 2019-08-15 No 4 A Direct
5,294 No 4 A Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $7.90 2017-10-08 38,820 38,820 Direct
Common Stock Stock Option (right to buy) $7.90 2017-10-08 6,470 6,470 Direct
Common Stock Restricted Stock Units $0.00 66,030 66,030 Direct
Common Stock Restricted Stock Units $0.00 2015-08-13 2015-08-13 2,749 2,749 Direct
Common Stock Restricted Stock Units $0.00 2016-08-31 2016-08-31 2,045 2,045 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-10-08 38,820 38,820 Direct
2017-10-08 6,470 6,470 Direct
66,030 66,030 Direct
2015-08-13 2,749 2,749 Direct
2016-08-31 2,045 2,045 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.62 to $22.89 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Fully exercisable.
  3. Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
  4. Represents restricted stock units held by reporting person previously reported as separate line items.
  5. Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning on the payment date.
  6. Represents restricted stock units received at the election of the reporting person, in lieu of cash payment, as a retainer for service as a director of the Company during fiscal year 2016.
  7. Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,324 shares on each of September 30, 2015 and December 31, 2015 and 1,323 shares on each of March 31, 2016 and June 30, 2016.